lysocin-e has been researched along with Tuberculosis* in 1 studies
1 other study(ies) available for lysocin-e and Tuberculosis
| Article | Year |
|---|---|
Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs.
Tuberculosis remains a public health crisis and a health security threat. There is an urgent need to develop new antituberculosis drugs with novel modes of action to cure drug-resistant tuberculosis and shorten the chemotherapy period by sterilizing tissues infected with dormant bacteria. Lysocin E is an antibiotic that showed antibacterial activity against Staphylococcus aureus by binding to its menaquinone (commonly known as vitamin K Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Mice; Mycobacterium tuberculosis; Peptides, Cyclic; Staphylococcus aureus; Streptomycin; Tuberculosis; Vitamin K 2 | 2022 |